ICEPHARMA A/S: Financial statements 2016
CVR: 36393459
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ICEPHARMA A/S (CVR 36393459) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 2,183,745 and a net result of DKK -3,769,542. Equity in the 2016 report amounted to DKK 187,820. The solvency ratio was 12.2%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 2,183,745
- Profit/Loss
- DKK -3,769,542
- Equity
- DKK 187,820
- Total Assets
- DKK 1,541,019
- Employees
- 5
Official annual report
Find more companies like ICEPHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of November 1, 2016, Hörður Þórhallsson is registered as director of ICEPHARMA A/S.
As of November 1, 2016, Peter Popowicz has stepped down as director of ICEPHARMA A/S.
ICEPHARMA A/S has published its interim report for the period September 30, 2014 – December 31, 2015.
About ICEPHARMA A/S
ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The board consists of Kristján Johannsson (chair), Jóhann Ingi Kristjánsson and Petrea Ingileif Gudmundsdottir. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.